The Journal of Practical Medicine ›› 2022, Vol. 38 ›› Issue (7): 786-790.doi: 10.3969/j.issn.1006⁃5725.2022.07.002

• Coronavirus（COVID-19） • Previous Articles     Next Articles

Research progress in drug therapy for COVID⁃19

JIANG Jingjing*，FENG Fujuan，GAO Chun，YU Xiaohui， ZHANG Jiucong.   

  1. Gansu University of Traditional Chinese Medicine，Lanzhou 730000，China；*Department of Gas⁃ troenterology，the 940 Hospital of Joint Logistic Support Force of PLA，Lanzhou 730050，China 

  • Online:2022-04-10 Published:2022-04-10
  • Contact: ZHANG Jiucong E⁃mail：zhangjiucong@163.com

Abstract:

From late December 2019，A form of COVID⁃19 caused by severe acute respiratory syndrome coronavirus 2（SARS⁃CoV⁃2）spread rapidly across the globe. Through active prevention，control and timely treat⁃ ment，the epidemic in China has been basically brought under control，with only local outbreaks and a few imported cases occurring in a few regions. However，the epidemic is still spreading in some countries and regions，and no specific drug is available for COVID⁃19 at present，so there is still an urgent need for effective and safe drugs to fight SARS⁃CoV⁃2 infection to control the pandemic of COVID⁃19 in the world. This article provides a brief review of the clinical use of drugs for the treatment of COVID⁃19 and their efficacy and safety.

Key words:

COVID?19, drugs, therapy, progress